CXCR4 and chronic myelogenous leukemia, BCR-ABL1 positive: CXCR4 activated its downstream PI3K/Akt signal pathway and promoted the translocation of NF-κB complexes into nucleus in CML cells, thereby decreasing the expression of apoptosis-related molecules [79].